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Introduction
Spinocerebellar ataxia type 5 (SCA5) is an autosomal dominant 
neurodegenerative disease that primarily affects the cerebellum. 
Affected patients have progressive cerebellar cortical atrophy 
and profound Purkinje cell loss. Similar clinical presentations 
reported in three different SCA5 families include upper and 
lower limb incoordination, slurred speech, and eye movement 
abnormalities. Age of onset typically occurs during the third or 
fourth decade of life, and symptoms worsen over time (Liquori 
et al., 2002). SCA5 is caused by mutations in the SPTBN2 gene, 
which encodes -III–spectrin, a cytoskeletal protein highly   
expressed in Purkinje cells (Ikeda et al., 2006). An American 
and a French SCA5 family have distinct, nonoverlapping in-
frame deletions in the third of the 17 spectrin repeats, and both 
of these deletions are predicted to disrupt the triple -helical 
structure of the spectrin repeat and the conformation of the 
spectrin tetramer. A third reported SCA5 family, from Germany, 
has a missense mutation in the second calponin homology domain. 
This region of the protein has been reported to bind actin and the 
ARP1 subunit of dynactin, providing a link between the actin cyto-
skeletal network and motor proteins (Holleran et al., 2001).
Although it is not yet clear how -III–spectrin mutations 
cause Purkinje cell death in SCA5 patients, several lines of evi-
dence have led to the proposal that SCA5 pathogenesis could re-
sult from the destabilization of specialized synaptic membrane 
domains and/or defects in intracellular transport. First, wild-type 
but not mutant -III–spectrin stabilizes the Purkinje cell– 
specific excitatory amino acid transporter 4 (EAAT4) at the sur-
face of the plasma membrane (Ikeda et al., 2006). In addition, 
cell fractionation studies have shown differences in the localiza-
tion of EAAT4 and the glutamate receptor delta 2 subunit 
(GluR2) in cerebellar synaptosomal fractions from SCA5 ver-
sus control autopsy tissue (Ikeda et al., 2006), and the C-terminal 
domains of GluR2 and EAAT4 have been shown to physically 
interact with spectrin (Hirai and Matsuda, 1999; Jackson et al., 
2001). Finally, -III–spectrin is a Golgi- and vesicle-associated 
protein that interacts with dynactin (Holleran et al., 2001). This 
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Figure 1.  Expression of mutant -III–spectrin causes a dosage-dependent and progressive neurodegenerative eye phenotype. (A) Scanning EM images 
of adult fly eyes grown at 25°C. Insets show higher magnification images of ommatidial fields. Expression of the American SCA5 mutation in human   
-III–spectrin in the eye results in a fused and disorganized ommatidia missing interommatidial bristles (II). Flies expressing the German SCA5 mutation 
in -III–spectrin show a mild roughness of the eye (III), with a more severe phenotype in flies expressing two copies of the German SCA5 transgene (V). 
Flies expressing wild-type -III–spectrin show only a mild ommatidial phenotype similar to gmr-GAL4 control flies (I and IV). Similar disruption of ommatidial 145 A Drosophila model of spinocerebellar ataxia type 5 • Lorenzo et al.
organization was observed when the mutant, but not wild-type, spectrin transgenes were expressed using the neuronal-specific nina E-GAL4 driver.   
(B, right) Bar graph showing mean ratios of myc-tagged spectrin versus tubulin protein for control gmr-GAL4/+, gmr-GAL4/+; hSPWT/+, gmr-GAL4/ 
hSPAM; gmr-GAL4/+; hSPGM/+, and homozygous gmr-GAL4/+; hSPGM/hSPGM flies. Animals expressing one copy of the hSPGM transgene have a 
significant reduction in -III–spectrin expression (P = 0.025, n = 4). Data represent mean ± SEM; *, P = 0.025. (B, left) -III–spectrin expression for the 
different genotypes was detected using an antibody to the myc epitope with tubulin as a loading control. (C–F) Histological sections of fly eyes. Longi-
tudinal frontal sections (C–F) and tangential sections (panels C–F) taken through the retina of 10-d-old flies. Images show thinning of the retinal layer 
(arrow) and loss of retinal neurons (arrowhead) in flies expressing the American (E and E) and German (F and F) SCA5 mutations compared with a 
wild-type control (D and D) and gmr-GAL4 driver flies (C and C). (G–J″) Optical eye images taken at days 10, 20, and 30 illustrate the progression 
of the eye phenotype. Flies expressing wild-type human -III–spectrin had external eye morphology similar to the gmr-GAL4 driver (G), and showed no 
changes in ommatidia organization and pigmentation during the first 30 d of adult life (H–H″). The eye phenotype of flies expressing the American mutant 
spectrin worsens considerably over time (I–I″). Flies expressing low levels of the German mutant spectrin have defects in pigmentation by day 30 (J″).   
(K and K) Optical eye images taken at days 2 and 10 correspond to flies expressing two copies of the hSPGM transgene. The severity and progression 
of the rough eye phenotype worsens with increasing dosage of mutant German -III–spectrin. (L) Protein extracts from flies expressing the wild-type human   
-III–spectrin transgene (gmr-GAL4/+; hSPWT/+) were subjected to immunoprecipitation using the anti–fly -spectrin monoclonal antibody 3A9. Precipi-
tated immune complexes were then analyzed by Western blotting assays using either anti-myc or anti-fly -spectrin antibodies. BSA was used as a control 
for the immunoprecipitation reaction. Bars: (C–F) 50 µm; (C–F): 5 µm; (G–K) 50 µm.
 
interaction is thought to be required for proper cargo attachment 
and motor activity (Muresan et al., 2001). Although data from 
in vitro biochemical experiments support a role for -III–spectrin 
in intracellular transport, in vivo models are needed to test if 
SCA5 mutations cause neuronal transport deficits.
Because Drosophila has proven to be an excellent organ-
ism to model basic cellular defects of human neurodegenerative 
disease (for review see Bilen and Bonini, 2005), we have devel-
oped a Drosophila model to investigate the molecular mecha-
nisms of SCA5. The fly genome contains one -spectrin, one 
conventional -spectrin, and one heavy spectrin (H-spectrin) 
gene, each of which is highly expressed at both central and   
peripheral synapses. Fly -spectrin shares 50% amino acid ho-
mology with human -III–spectrin, as well as conservation of 
all functional domains, including each of the regions containing 
the human mutations (Fig. S1 A, I and II).
Similar to human -III–spectrin, fly -spectrin has also been 
implicated in membrane stabilization and intracellular transport 
functions. Loss or reduced expression of fly -spectrin in neurons 
results in severe defects in the formation and stabilization of syn-
aptic junctions (Pielage et al., 2005, 2006). Segmental axons from 
larvae in which expression of -spectrin has been ubiquitously   
abolished or conditionally eliminated in neurons show aberrant   
distribution of synaptic proteins, which accumulate within axonal 
swellings (Featherstone et al., 2001; Pielage et al., 2005, 2006).
Here, we show that expression of SCA5 mutant, but not 
wild-type, -spectrin proteins causes neurodegeneration in the 
fly eye and deficits in synapse formation at the neuromuscular 
junction (NMJ). Additionally, we present live imaging and ge-
netic evidence that the SCA5 mutations disrupt intracellular 
transport, a basic cell biological process also implicated in sev-
eral  other  neurodegenerative  diseases  including  amyotrophic 
lateral sclerosis and Huntington’s disease (De Vos et al., 2008).
Results
Expression of human SCA5 mutant  
-III–spectrins cause dosage-dependent, 
progressive neurodegeneration in the 
Drosophila eye
To understand the molecular mechanisms of SCA5, we cloned 
the  full-length  myc-tagged  human  SPTBN2  cDNA  carrying 
the wild-type sequence (human spectrin wild type [hSPWT]), 
mutations found in an American family descended from Presi-
dent Abraham Lincoln’s paternal grandparents (human spectrin 
American mutation [hSPAM]; Ikeda et al., 2006), or a German 
family (human spectrin German mutation [hSPGM]; Ikeda   
et al., 2006) into the transformation vector pUASp (Fig. S1 B) 
and performed embryo injections. The resulting transgenic flies 
were crossed to the eye-specific gmr-GAL4 driver (Freeman, 
1996) to ectopically express the human transgenes in the eye. 
Expression of human -III–spectrin with the American family 
mutation  (gmr-GAL4/hSPAM)  results  in  a  severe  rough  eye 
phenotype characterized by disorganized ommatidia and loss of 
mechanosensory bristles (Fig. 1 A, II), whereas expression of 
the German mutant spectrin (gmr-GAL4/+; hSPGM/+) causes 
a milder eye phenotype (Fig. 1 A, III). In contrast, expression 
of wild-type human -III–spectrin (gmr-GAL4/+; hSPWT/+) 
causes only a very mild ommatidial phenotype that does not 
disrupt normal eye development (Fig. 1 A, IV) and is similar 
to the control driver flies (gmr-GAL4/+; Fig. 1 A, I). Protein 
analysis shows that flies expressing wild-type (gmr-GAL4/+; 
hSPWT/+)  and  the  American  mutant  spectrin  (gmr-GAL4/ 
hSPAM) produce comparable levels of transgenic protein, whereas 
flies  expressing  the  German  mutant  spectrin  (gmr-GAL4/+; 
hSPGM/+) have significantly lower -III–spectrin expression 
(Fig. 1 B; P = 0.025, n = 4). As expected the phenotypes are dos-
age dependent; flies carrying two copies of the hSPGM trans-
gene (gmr-GAL4/+; hSPGM/hSPGM) express higher levels of 
-III–spectrin compared with the heterozygous flies (Fig. 1 B) 
and develop a stronger rough eye phenotype (Fig. 1 A, V).
To determine if the SCA5 spectrin mutations affect retinal 
neurons, histological analysis was performed. Sections taken 
through the eye of 10-d-old flies showed a severe disruption of 
the retinal organization, with thinning of the retina and loss of 
retinal neurons in flies expressing the American and German 
SCA5 mutations (Fig. 1, E, E, F, and F, see arrows) compared 
with the gmr-GAL4 driver line (Fig. 1, C and C) or flies ex-
pressing wild-type -III–spectrin (Fig. 1, D and D). Analysis 
of flies expressing the SCA5 mutations revealed that the extent 
of neurodegeneration in the eye became more severe as flies 
aged. By day 30, eyes from flies expressing the American SCA5 
mutation showed dramatic changes in pigmentation and abun-
dant necrotic tissue (Fig. 1, I–I″). Similarly, heterozygous flies JCB • VOLUME 189 • NUMBER 1 • 2010   146
expressing low levels of the German SCA5 mutation developed 
eye pigmentation abnormalities by day 30 (Fig. 1, J–J″), whereas 
homozygous flies expressing higher levels of German mutant 
spectrin showed dramatic changes in eye pigmentation by   
day two, and patches of severe necrosis by day 10 (Fig. 1,   
K and K). In contrast, no changes in external eye morphology or   
pigmentation were found in control flies expressing wild-type 
-III–spectrin (Fig. 1, H and H″). Taken together, these results 
demonstrate that expression of human -III–spectrin containing 
either the American or German mutations causes a progressive, 
dominant neurodegenerative phenotype.
The basic structural unit of the spectrin network is a dimer 
formed by direct association between - and -spectrin sub-
units (for review see Bennett and Baines, 2001). To begin to un-
derstand the molecular basis for the observed neurodegenerative 
phenotypes, we tested whether human -III–spectrin assembles 
into the fly /-spectrin complex by immunoprecipitation   
(Fig. 1 L). Proteins from flies expressing wild-type human   
-III–spectrin in the eye were immunoprecipitated with anti-fly 
-spectrin antibody, and protein blot analysis shows that human 
-III–spectrin and fly -spectrin interact. This result indicates 
that the human -III–spectrin does appear to incorporate into 
the /-spectrin complexes in flies.
Human -III–spectrin and fly  
-spectrin share some binding partners  
and functional pathways
To further characterize the effects of the SCA5 mutations, we 
developed a second set of transgenic flies in which the human 
SCA5 mutations were incorporated into Drosophila cDNA con-
structs designed to overexpress wild-type (fly spectrin wild type 
[FSPWT]) and mutant fly -spectrins (fly spectrin American 
Figure  2.  Human  -III–spectrin  and  fly 
-spectrin  share  functional  pathways.  (A) 
Scanning EM images of adult eyes from flies 
grown at 25°C. Insets show higher magnifica-
tion images of the ommatidia field. Expression 
of fly -spectrin carrying either the American 
(gmr-GAL4/+; FSPAM/+, II) or German (gmr-
GAL4/FSPGM,  III)  SCA5  mutations  in  the 
adult fly eye results in a neurodegenerative 
eye  phenotype.  Overexpressing  wild-type 
fly -spectrin (gmr-GAL4/FSPWT, I) results in 
minor  changes  in  the  external  morphology 
of the eye similar to the gmr-GAL4 control.   
(B,  top)  Total  proteins  from  fly  heads  were 
analyzed by Western blotting using an anti-
body  that  recognizes  fly  -spectrin.  Tubulin 
was used as a loading control. The black line 
indicates  that  intervening  lanes  have  been 
spliced out. (B, bottom) Bar graphs showing 
mean  ratios  of  fly  -spectrin  versus  tubulin 
protein. The expression of fly -spectrin in 
each transgenic line was similar and approx-
imately  twice  the  endogenous  level  of  pro-
tein detected in the gmr-GAL4/+ driver line   
(P = 0.18, n = 4). Error bars indicate mean ± 
SEM (error bars); *, P = 0.18.147 A Drosophila model of spinocerebellar ataxia type 5 • Lorenzo et al.
ommatidial disorganization comparable to gmr-GAL4/+ flies 
(gmr-GAL4/FSPWT; Fig. 2 A, I). These data suggest that human 
-III and fly -spectrin act in at least some of the same func-
tional pathways when expressed in the fly and support the use 
of these models to study dominant or dominant-negative effects 
of the SCA5 mutations.
Mutant -spectrin impairs synaptic 
terminal growth at the NMJ
We additionally explored the effects of the SCA5 mutations by 
expressing the human and fly -spectrin transgenes in all neu-
rons using the elav-GAL4 driver, and examined synaptogenesis 
mutant [FSPAM] and German mutant [FSPGM]; Fig. S1 C). 
Analysis of protein expression indicates that transgenic lines for 
each of the genotypes in this study have comparable and approx-
imately twofold higher levels of fly -spectrin than the endog-
enous spectrin detected in the gmr-GAL driver line (Fig. 2 B;   
P = 0.18, n = 4).
Similar to the human mutant -III–spectrin transgenes, 
the expression of the fly -spectrin transgenes containing ei-
ther  the American  (FSPAM)  or  German  (FSPGM)  mutation 
also produced strong degenerative eye phenotypes (Fig. 2 A, 
II and III). In contrast, animals overexpressing wild-type fly   
-spectrin do not develop eye degeneration and only show mild 
Figure 3.  Spectrin mutations affect synap-
tic terminal size at the NMJ.  (A–G)  Confo-
cal fluorescence images of NMJs on ventral 
longitudinal muscles 6/7 of larval abdominal 
segments 2 and 3. Larval synapses were vi-
sualized by staining with an antibody to the 
synaptic vesicle–associated protein CSP. Neu-
ronal expression of the hSPAM, FSPAM, and 
FSPGM transgenes driven by elav-GAL4 re-
sults in less NMJ expansion and fewer synap-
tic boutons and branches (B, E, and F) when 
compared with the elav-GAL4 driver line (G). 
Neuronal expression of hSPWT, hSPGM, or 
FSPWT  transgenes  did  not  affect  synapse 
size (A, C, and D). Bars, 50 µm. (H) Quanti-
fication of bouton number shows a significant 
reduction in synapse size (number of synaptic 
boutons per surface area of muscle 6/7) in 
larvae expressing the hSPAM, FSPAM, and 
FSPGM mutant transgenes (***, P < 0.001). 
Numbers are normalized to elav-GAL4 in the 
graph. Data are mean ± SEM (error bars).JCB • VOLUME 189 • NUMBER 1 • 2010   148
Figure 4.  Spectrin mutations disrupt the axonal transport of synaptic vesicles. (A) Larvae overexpressing wild-type fly -spectrin (elav-GAL4/+; FSPWT/+) 
exhibited normal posture when crawling. (B and C) Mutant larvae (elav-GAL4/+; FSPAM/+ and elav-GAL4/+; FSPGM/+) developed the posterior paraly-
sis phenotype common to axonal transport mutants in Drosophila. Videos of larval crawling can be seen in Videos 1–3. (D–F) The distribution of vesicular 
syt-GFP along larval segmental axons. Expression of the American and German mutant spectrins cause large syt-GFP accumulations (E and F) when compared 149 A Drosophila model of spinocerebellar ataxia type 5 • Lorenzo et al.
Martin et al., 1999; Bowman et al., 2000; Haghnia et al., 2007). 
Larvae expressing mutant but not wild-type fly -spectrin in 
neurons exhibit the tail flip crawling phenotype due to paralysis 
of the posterior segments of the larval body (Fig. 4, A–C; and 
Videos 1–3). Although larvae expressing one copy of the human 
-III–spectrin transgenes (elav-GAL4/+; hSPAM/+ and elav-
GAL4/+; hSPGM/+) did not develop similar motor defects, this 
likely  reflects  the  lower  levels  of  human  protein  expression 
compared with fly -spectrin. Consistent with this idea, animals 
expressing two copies of the American mutant spectrin trans-
gene (elav-GAL4/+; hSPAM/hSPAM) produce higher levels of 
mutant spectrin protein and exhibit the tail flip phenotype in 
31% of the larvae (10/32 larvae; Video 4). By comparison, 
control animals expressing two wild-type copies of the spectrin 
transgene (elav-GAL4/+; hSPWT/hSPWT) at comparable pro-
tein levels exhibit a tail phenotype in only 5% of the larvae 
(2/40 larvae). In addition, if one copy of the endogenous   
-spectrin gene is silenced by mutation, then a single copy of 
the hSPAM mutant transgene produces posterior paralysis in 
32% (12/38) of larvae. In the control cross, a single copy of 
the  wild-type  human  spectrin  transgene  (hSPWT)  produced   
paralysis in <5% of the larvae (2/41). Finally, we show that 
RNAi depletion of the endogenous -spectrin produces paraly-
sis in 88% (29/33) of larvae, and that the introduction of two 
copies of the hSPWT transgene rescues the paralysis in 90% 
of the larvae (4/38 paralyzed). In summary, the dosage depen-
dence of the hSPAM larval paralysis phenotype suggests that 
human and fly mutant spectrins interfere with the normal func-
tions of wild-type -spectrin, and that these dominant-negative 
effects are likely to contribute to disease.
Mutant spectrin affects both the 
anterograde and retrograde transport  
of synaptic vesicles
To determine if the larval tail paralysis and synaptogenesis pheno-
types could be explained by defects in axonal transport, we 
analyzed the distribution of GFP-tagged synaptic vesicle mem-
brane protein syt-GFP. In larvae expressing wild-type -spectrin 
(elav-GAL4–syt-GFP/+; FSPWT/+), syt was evenly distributed 
as small puncta (Fig. 4 D). In contrast, larvae expressing mutant 
spectrins  (elav-GAL4–syt-GFP/+;  FSPAM/+  and  elav-GAL4–
syt-GFP/+; FSPGM/+) showed an accumulation of syt-GFP–
positive vesicles within axonal aggregates (Fig. 4, E and F, see 
arrows). Considering that segmental axons have a mean diameter 
of 0.5 µm (Rusu et al., 2007), we next quantified the number 
of large syt accumulations (diameter ≥ 0.7 µm), which are likely 
to cause axonal swellings and disrupt the normal trafficking of   
at the NMJ in third instar larvae (Fig. 3, A–G). Quantitative re-
sults are reported as relative synapse size (bouton number per 
muscle area; see Materials and methods) to account for differ-
ences in bouton number caused by variations in muscle size 
during normal growth. We observed reduced bouton number in 
larvae expressing mutant hSPAM, FSPAM, and FSPGM but not 
the wild-type (hSPWT and FSPWT) transgenes (P < 0.0001; 
Fig. 3). Although, under the same conditions, we did not detect 
differences in bouton counts in larvae expressing the hSPGM 
transgene (Fig. 3 C), this result is likely explained by the rela-
tively low expression in this line (Fig. 1 B).
To further characterize the synaptic phenotype, we ex-
amined the organization of several proteins that are known 
to contribute to the spectrin-mediated development and stabil-
ity of the NMJ (Pielage et al., 2006, 2008; Koch et al., 2008). 
In wild-type animals, the transynaptic cell adhesion molecule   
fasciclin II (Fas II) is organized in a honeycomb-like distribution 
that surrounds presynaptic active zones. In contrast, SCA5 mu-
tant larvae have defects in the organization and morphology of 
synaptic boutons and in the distribution of Fas II throughout the 
synapse (Fig. S2) that are similar to the phenotypes described in 
-spectrin RNAi lines. In addition, we show that the expression 
of mutant SCA5 transgenes does not result in synapse retrac-
tion, in contrast to results described for flies lacking -spectrin 
expression at the NMJ (Pielage et al., 2005, 2006). Despite the 
reduction in the number of synaptic boutons observed in SCA5 
mutant animals, most presynaptic terminals were found to re-
side in opposition to postsynaptic membranes, as indicated by 
costaining with the synaptic markers synaptotagmin (syt) and 
dics large (Dlg; Fig. S3, A–I). Our studies also show that mutant 
spectrin does not impair the localization of ankyrin at synaptic 
sites (Fig. S3, J–R) or affect microtubule organization within 
the axon and NMJ (Fig. S4). Taken together, these data demon-
strate that the phenotypes induced by overexpression of mutant   
human and fly -spectrin overlap, but are distinct from pheno-
types previously reported by RNAi depletion of -spectrin 
(Pielage et al., 2005).
Mutant -spectrin expression impairs  
larval locomotion
The reduced synaptic growth observed in animals expressing 
mutant spectrins suggests the possibility that intracellular trans-
port deficits contribute to the structural abnormalities at the syn-
apse. To test this hypothesis, we examined larvae expressing the 
American and German SCA5 mutations for the posterior paraly-
sis or “tail-flip” phenotype previously described for mutations 
that cause aberrant axonal transport (Hurd and Saxton, 1996; 
with the punctuated pattern seen in axons expressing the wild-type protein (D). Large axonal swellings are indicated by arrows. (G) Quantification of the   
number of syt-GFP accumulations in 50 µm of axonal length. At least 15 segmental nerves were analyzed per genotype. Data represent mean ± SEM   
(error bars). Significant differences in the number of axonal jams between wild-type and mutants are denoted by asterisks (***, P < 0.001). (H) Fluorescent 
images of segmental nerves show the accumulation of the axonal transport cargoes syt and CSP within the axonal jams in segmental nerves from mutant 
but not wild-type fly -spectrin larvae. (I) Fluorescent images of segmental axons show the accumulation of the motor protein dynein and the synaptic vesicle 
integral membrane protein syt in mutant but not wild-type fly -spectrin larvae. (J) Representative kymographs showing the motion of individual syt-GFP 
particles in larval segmental axons as a function of time. Kymographs corresponding to larvae expressing wild-type fly -spectrin (elav-GAL4/+; FSPWT/+) 
show fluorescent vesicles moving in one defined direction (diagonal lines), and few stationary vesicles appear as vertical lines (I and II). Kymographs from 
mutant spectrin larvae show stationary GFP particles, whereas the majority of those moving undergo numerous reversals in the direction of movement that 
appear as zigzag lines (III and IV). Bars, 10 µm.
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intracellular cargoes (Gunawardena and Goldstein, 2001). We 
found a significant difference (Fig. 4 G; ***, P < 0.0001) in the 
frequency of axonal jams in larvae expressing mutant FSPAM 
and FSPGM transgenes (Fig. 4 G) compared with wild-type con-
trols. In addition, we show that the distributions of the synaptic 
vesicle protein, cysteine string protein (CSP; Fig. 4 H), as well as 
the dynein motor protein (Fig. 4 I), overlap with sites of syt-GFP 
axonal aggregates (Fig. 4, H and I).
To  determine  the  effects  of  the  SCA5  mutations  on 
synaptic vesicle transport, we imaged and tracked the dy-
namic behavior of vesicles in live segmental axons. In flies   
overexpressing wild-type -spectrin, a large number of syt- 
  GFP–containing vesicles underwent rapid unidirectional move-
ments. Kymograph analysis shows that this motion is character-
ized by long unidirectional runs (Fig. 4 J, I and II, diagonal 
line) interrupted by pauses and/or infrequent short reversals 
in the direction of vesicle transport (Fig. 4 J, I and II; and 
Video 5). In contrast, in segmental axons expressing either 
the American or German SCA5 mutations, the unidirectional 
bias in vesicle movement was reduced. Syt-GFP vesicles exhib-
ited frequent reversals in the direction of transport (Fig. 4 J, 
zigzag line), traveling for much shorter distances in any one 
direction. Representative kymographs and videos that illus-
trate the behavior of synaptic vesicles in mutant -spectrin 
axons are shown in Fig. 4 J (III and IV) and Video 6. In ad-
dition, quantitative analysis confirmed that syt-GFP vesicles 
moved significantly slower in mutant compared with wild-
type axons (Table I). Competition by the mutant spectrins may 
alter the dynamics of motor attachment to vesicular cargo 
and/or interfere with the binding of regulatory partners that 
influence motor activity.
To  assess  whether  mutant  -spectrin  affects  antero-
grade, retrograde, or both types of axonal transport, mutant 
spectrin and the vesicle marker neuronal synaptobrevin-GFP 
(n-syb-GFP) were expressed using the motor neuron–specific   
D42-GAL4 driver. In control larvae (D42-GAL4–n-syb-GFP/
FSPWT), most fluorescent particles were moving in long runs 
(Video 7). In contrast, animals expressing either of the mu-
tant spectrins (D42-GAL4–n-syb-GFP/FSPAM and D42-GAL4– 
n-syb-GFP; FSPGM) showed numerous stationary n-syb-GFP 
particles, some of which were trapped within axonal swellings 
(Video 8). Analysis of mean velocity and run length for antero-
grade and retrograde movements indicate that mutant spectrin 
disrupts transport in both directions (Table II), and that the GFP 
vesicles that retained motility had slower velocities and traveled 
shorter distances than in controls.
Dynein–dynactin deficits genetically enhance 
spectrin-induced phenotypes
The rough eye and transport phenotypes caused by the mutant 
spectrins are similar to phenotypes previously described in dynein 
and dynactin mutants (McGrail et al., 1995; Martin et al., 1999; 
Boylan et al., 2000). If these phenotypes result from the failure of 
spectrin to properly engage in retrograde transport, then we would 
predict that dynein, and/or dynactin mutations, would enhance the 
mutant spectrin phenotypes. To test this hypothesis, flies carry-
ing a hypomorphic dynein heavy chain allele (DHC64C
6-10) were 
crossed to flies containing a single copy of the hSPAM transgene, 
and progeny were scored for posterior paralysis. In contrast to sin-
gle mutant animals, which do not show posterior paralysis, larvae 
expressing both spectrin and dynein mutations (elav-GAL4–syt-
GFP/+; hSPAM/+; DHC64C
6-10/+) develop the tail flip (Fig. 5 A, 
III) and axonal vesicle accumulation phenotypes (Fig. 5 B, III). 
Additionally, double mutant larvae display significant reductions 
in synapse size at the NMJ compared with single mutant con-
trols as well as hSPWT and elav-GAL4 animals (Fig. 5 C; ***,   
P < 0.0001). A similar genetic interaction occurs between flies 
expressing the American mutation and the dominant Gl
1 muta-
tion in the p150
Glued subunit of dynactin. We observed larval pa-
ralysis in 44% (22/50) of progeny carrying the American spectrin   
Table I.  Analysis of syt-GFP vesicles motions in segmental nerves expressing wild-type or mutant -spectrin driven by elav-GAL4
Genotype Net velocity
a Number of particles P-value
µm/s ± SD
elav-GAL4/+; FSPWT/+ 0.75 ± 0.23 89 NA
elav-GAL4/+; FSPAM/+ 0.43 ± 0.2* 88 < 0.0001
elav-GAL4/+; FSPGM/+ 0.48 ± 0.15* 86 < 0.0001
Asterisks denote significant differences for mutant relative to wild-type. NA, not applicable.
aNet velocity was determined by adding all velocities for each tracked GFP particle over the entire time of motion. Data shown represent mean ± SD.
Table II.  Analysis of transport parameters for anterograde and retrograde syb-GFP containing vesicles in wild-type and mutant segmental 
nerves
Genotype Anterograde runs Retrograde runs
Velocity P-value Run length P-value n Velocity P-value Run length P-value n
µm ± SD µm/s ± SD µm/s ± SD µm ± SD
D42-GAL4; FSPWT 0.78 ± 0.13 NA 9.6 ± 2.5 NA 54 0.72 ± 0.15 NA 9.2 ± 3.1 NA 80
D42-GAL4/FSPAM 0.5 ± 0.17* <0.0001 6.8 ± 3.1* <0.0001 76 0.55 ± 0.11* <0.0001 7.2 ± 2.5* <0.0001 97
D42-GAL4; FSPGM 0.44 ± 0.15* <0.0001 6.1 ± 2.7* <0.0001 81 0.48 ± 0.18* <0.0001 7.4 ± 3.3* <0.0001 135
Mean velocity and run length for both anterograde and retrograde moving particles are reduced in mutant -spectrin larvae in comparison to wild type. Data shown 
represent mean ± SD. Asterisks denote statistical significant differences for mutant relative to wild type. NA, not applicable.151 A Drosophila model of spinocerebellar ataxia type 5 • Lorenzo et al.
Figure  5.  DHC64C  and  p150
Glued  mutant  alleles  enhance  the  dominant  neurodegenerative  phenotypes  associated  with  the  SCA5  mutations.  
(A) Mutations in human -III–spectrin interact with the cytoplasmic dynein heavy chain DHC64C
6-10 mutation to produce posterior paralysis. Larvae   
shown in A I and A II are heterozygous for the American SCA5 mutation in human -III–spectrin (elav-GAL4–syt-GFP/+, hSPAM/+) and the DHC64C
6-10   
mutant allele, respectively, and exhibit normal locomotion. Double heterozygous animals (elav-GAL4–syt-GFP/+, hSPAM/+, DHC64C
6-10/+) de-
veloped  an  abnormal  crawling  behavior  (A  III).  (B)  Fluorescent  images  show  large  syt-GFP  accumulations  within  segmental  nerves  from  dou-
ble  heterozygous  mutant  larvae  (B  III,  elav-GAL4–syt-GFP/+,  hSPAM/+,  DHC64C
6-10/+).  Bar,  10  µm.  (C)  Quantification  of  bouton  number 
shows a significant reduction in synapse size (number of synaptic boutons per surface area of muscle 6/7) in animals expressing the Amer-
ican  SCA5  mutation  in  human  -III–spectrin  that  are  also  heterozygous  for  the  DHC64C
6-10  mutant  allele  of  dynein  (elav-GAL4–syt-GFP/+,   
hSPAM/+, DHC64C
6-10/+). Numbers are normalized and compared with the elav-GAL4/+;hSPWT/+ control line in the graph. Data are mean ± 
SEM (error bars); ***, P < 0.001. (D–K) Scanning EM images of Drosophila eyes. Insets show higher magnification images of the ommatidial 
field. Recombinant lines expressing the American SCA5 mutation in -III–spectrin (gmr-GAL4-hSPAM/CyO, 5D) or the German SCA5 mutation 
in fly -spectrin (gmr-GAL4-FSPGM/CyO, 5E) show disorganization in the arrangement of the ommatidia and bristles of the adult eye. Note 
that the recombinant gmr-GAL4-hSPAM line showed reduced levels of transgene expression and produced a less severe eye phenotype, mak-
ing it easy to distinguish changes in the phenotype. DHC64C
6-10/+ flies have a wild-type eye (F) but, in combination with gmr-GAL4-hSPAM or 
gmr-GAL4-FSPGM mutant spectrin alleles, produce a more severe eye phenotype than either parent (G and H). Eyes expressing the dominant 
Gl
1 mutation exhibit a rough eye phenotype, with disordered ommatidia (I). Similarly, the combination of the Gl
1 dynactin mutant allele and   
gmr-GAL4-hSPAM or gmr-GAL4-FSPGM mutant spectrins results in a dominant enhancement of the eye degeneration. Eyes from double mutant flies 
are reduced in size and show a dramatic roughens of the eye surface (J and K). Bars in D also apply to F–I.JCB • VOLUME 189 • NUMBER 1 • 2010   152
expressed in Purkinje cells, lead to a dominantly inherited form 
of ataxia (Ikeda et al., 2006). We have used ectopic expression 
of human -III–spectrin and overexpression of endogenous fly 
-spectrin to define the basic biological processes affected by 
the SCA5 mutations and to better understand the mechanisms 
of neurodegeneration. Our observations suggest that the human 
SCA5 mutations cause dominant-negative effects. Consistent 
with this hypothesis are data showing that the severity of the 
eye  and  larval  phenotypes  found  in  flies  expressing  mutant   
-spectrin increases when the levels of endogenous wild-type 
spectrin are reduced. Our observations do not exclude the   
possibility that the SCA5 mutations may also cause abnormal-
ities in protein stability and conformation that result in addi-
tional dominant gain-of-function effects. Future studies will 
be needed to evaluate the relative contributions of these mecha-
nisms to the neurodegenerative Purkinje cell phenotypes seen 
in SCA5 patients.
The position of the German mutation in the second cal-
ponin homology domain suggests that the mutant protein dis-
rupts  the  normal  interactions  of  the  wild-type  protein  with 
the  actin  cytoskeleton  and/or  the ARP1  subunit  of  dynactin   
(Holleran et al., 2001). Consistent with these data, both the   
German and the American mutations cause intracellular trans-
port deficits that are similar to the phenotypes of mutant Arp1 
flies (Haghnia et al., 2007). In the case of the American family, 
the deletion within the third spectrin repeat may result in similar 
effects on dynactin pathways by disrupting protein–protein inter-
actions that depend on the helical conformation of the spectrin 
repeats, and the formation of stable -–spectrin tetramers. The 
similar phenotypes found in flies expressing the SCA5 mutations 
in the context of either the human or fly -spectrin proteins in-
dicate that many of the binding partners and functional roles of 
spectrin are conserved between humans and flies. Indeed, anti-
bodies specific for Drosophila -spectrin can immunoprecipitate   
human -III–spectrin from protein extracts (Fig. 1 L), and the 
human -III–spectrin can rescue the larval tail paralysis induced 
after RNAi depletion of fly -spectrin.
In Drosophila, the single -spectrin gene product is the 
orthologue of vertebrate -spectrins 1, 2, 3, and 4. Thus, our 
studies suggest that all vertebrate -spectrins are likely capable 
of post-Golgi transport while potentially targeted to specific 
subsets of vesicular cargoes. As previously suggested (Bennett 
and Baines, 2001), it is unlikely that human -III–spectrin is a 
general Golgi-specific protein, as axonal transport involves the 
trafficking of post-Golgi structures (Horton and Ehlers, 2003; 
Ye  et  al.,  2007).  Moreover,  the  expression  of  human -III– 
spectrin is highly enriched in the cerebellum and nervous sys-
tem (Sakaguchi et al., 1998), a distribution that is consistent 
with the localized atrophy of the cerebellar hemispheres and the 
neurological symptoms of SCA5 patients.
Drosophila model for SCA5
Overexpression of wild-type and mutant spectrin in Drosophila 
neurons allows us to investigate the pathways that contribute to 
spectrin function and regulation, and should provide insight 
into the molecular basis of SCA5 pathology. Although a simi-
lar approach has been exploited to study a number of other   
transgene  in  a  p150
Glued  mutant  background  (elav-GAL4– 
syt-GFP/+; hSPAM/+; Gl
1/+), whereas only 5% (5/50) of sib-
ling progeny expressing the mutant spectrin transgene in the 
absence of the Gl
1 (elav-GAL4–syt-GFP/+; hSPAM/+; Tb/+) 
exhibited larval paralysis. Sibling progeny (hSPAM/+; Gl
1/+) 
that lack the elav-GAL4 driver showed the tail paralysis pheno-
type in 18% (9/50) of larvae. Additionally, the rough eye phe-
notypes caused by the expression of the SCA5 mutant spectrin 
are enhanced by dynein and dynactin mutations. This analysis 
was facilitated by the generation of recombinant lines that carry 
both the GAL4 driver and the mutant spectrin transgenes (gmr-
GAL4-hSPAM or gmr-GAL4-FSPGM) on a single chromosome 
(Fig. 5 D). The recombinant chromosomes, which have reduced 
levels of transgene expression (Fig. S5 A) develop a less severe 
eye phenotype (Fig. 5 D), which allowed genetically enhanced 
phenotypes to be more easily detected. Adult flies with one 
copy of the American or German mutant spectrin transgenes, 
which are also heterozygous for a hypomorphic mutant dynein 
allele, DHC64C
6-10, exhibit severe eye phenotypes involving 
disruptions of the ommatidial hexagonal packing and loss of 
interommatidial bristles (gmr-GAL4-hSPAM/+; DHC64C
6-10/+ 
and gmr-GAL4-FSPGM/+; DHC64C
6-10/+; Fig. 5, G and H). 
In contrast, fly strains carrying only the mutant spectrin trans-
gene or the dynein mutation exhibit only mild or wild-type eye 
phenotypes (Fig. 5, D–F). Similarly, the dominant Gl
1 dynac-
tin mutation, which by itself causes disorganization of the om-
matidia (Fig. 5 I), genetically enhances the phenotypes of flies 
expressing either the American or German spectrin mutations 
(gmr-GAL4-hSPAM/+; Gl
1/+ and gmr-GAL4-FSPGM/+; Gl
1/+;   
Fig. 5, J and K). We excluded the possibility that these genetic 
interactions simply result from alterations in spectrin expres-
sion by protein blotting (Fig. S5, B and C). The genetic interac-
tions observed are consistent with the functional intersection of 
the dynein and spectrin pathways.
Discussion
We have established a series of transgenic Drosophila models to 
investigate the molecular mechanisms of spinocerebellar ataxia 
type 5. Toward these goals, we show that expression of the 
American family and German SCA5 mutations in flies causes 
neurodegenerative changes in the adult eye as well as motor   
coordination, synaptogenesis, and axonal transport deficits in 
Drosophila larvae. These phenotypes are genetically enhanced 
by partial loss-of-function mutations in dynein or a dominant-
negative mutation in the p150
Glued component of dynactin. Taken 
together, these data demonstrate that SCA5 mutations can   
trigger adult-onset neurodegeneration in the fly eye and affect   
fundamental intracellular transport functions that are likely to 
play a role in this progressive neurodegenerative disease.
SCA5 mutations cause dominant  
dosage-dependent phenotypes
In Drosophila, previous work has established that the single   
- and -spectrin genes are essential (Dubreuil et al., 2000). 
In contrast, in humans there are four -spectrin genes, and muta-
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human neurodegenerative diseases (e.g., Feany and Bender, 
2000;  Jinet  al.,  2003;  Gunawardena  et  al.,  2003;  Jung  and   
Bonini, 2007), this approach does have limitations. In contrast 
to the human disease, mutant spectrin is expressed in the pres-
ence of two copies of the endogenous wild-type fly -spectrin 
gene. Although it would be interesting to compare the effects 
of the SCA5 mutations using a knock-in approach in which a 
single mutant and single wild-type -spectrin allele are ex-
pressed,  Drosophila  has  only  a  single,  essential  -spectrin 
gene that is widely expressed in multiple tissues. This would 
limit the types of analyses that could be performed and compli-
cate the interpretation of knock-in phenotypes. Moreover, such 
a knock-in fly model would not mimic the human situation in 
which four -spectrin genes and a variety of / heterotetra-
mers  exhibit  distinct  functions  and  patterns  of  expression.   
Although no Drosophila model, including the one character-
ized in this study, can perfectly model a human disease, we 
demonstrate that the SCA5 mutant -III–spectrins act within 
the normal spectrin pathway, competing with endogenous Dro-
sophila -spectrin to produce dosage-dependent phenotypes. 
We suggest that the phenotypes caused by overexpression of 
SCA5 mutant but not wild-type spectrin in our models provide 
insight into the molecular consequences of the mutations that 
are likely to be helpful in understanding the molecular mecha-
nisms underlying the human disease.
SCA5 mutations cause synaptic deficits
The major roles of spectrin in strengthening cellular membranes 
and organizing ion channels, neurotransmitter receptors, cell ad-
hesion  molecules,  and  other  components  into  specialized 
synaptic membrane domains are well established (Bloch and 
Morrow, 1989; Jenkins and Bennett, 2001; Lee and Discher, 
2001; Komada and Soriano, 2002; Lacas-Gervais et al., 2004; 
Hammarlund et al., 2007; Bennett and Healy, 2008). In par-
ticular, recent work suggests that wild-type -III–spectrin, 
but not SCA5 mutant spectrin, can stabilize the glutamate 
transporter EAAT4 at the cell membrane (Jackson et al., 2001; 
Ikeda et al., 2006).
Consistent with possible dominant-negative effects, ex-
pression of the SCA5 mutant proteins results in reduced num-
bers of synaptic boutons at synaptic termini. In Drosophila, 
spectrin function at the synapse has been extensively studied in 
motor neurons (Featherstone et al., 2001; Pielage et al., 2005, 
2006). These studies first characterized pre- and postsynaptic 
spectrin localization and function during motor neuron synap-
togenesis in Drosophila. Loss of presynaptic spectrin report-
edly eliminates several essential cell adhesion molecules from 
synaptic sites and leads to defects in neurotransmission and the 
disassembly and elimination of synapses at the NMJ (Pielage   
et al., 2005, 2006). In addition, the RNAi depletion of presynap-
tic -spectrin has been reported to disrupt microtubule organiza-
tion at the terminal boutons, to generate large accumulations of 
synaptic vesicles with motor axons, and to reduce the accumu-
lation of synaptic vesicles within the terminal boutons. These 
latter studies suggested a link between spectrin and vesicle 
transport either through a direct role in motor-based transport 
or an indirect affect on cytoskeletal organization. Although we 
observed similar defects in synaptic growth and trafficking in   
axons expressing mutant SCA5 spectrin, we also detected sev-
eral distinct phenotypes. For example, synaptic retraction and 
loss of Fas II and Ank was reported when -spectrin is depleted 
by RNAi (Pielage et al., 2005, 2006; Koch et al., 2008), but these 
phenotypes are not found in animals expressing SCA5 mutant 
spectrins. Additionally, we did not observe dramatic alterations 
in synaptic microtubule distribution as previously reported after 
depletion of presynaptic -spectrin (Pielage et al., 2005).
To test the possible role that transport deficits play in these 
phenotypes, we performed a series of genetic interaction stud-
ies. We show that loss of synapses at the NMJ in SCA5 mutant 
flies  is  enhanced  in  animals  heterozygous  for  dynein-heavy 
chain and p150
Glued mutations. These genetic interactions sug-
gest that spectrin, dynein, and dynactin interact in a complex 
that mediates synapse stabilization. Although the protein inter-
actions that mediate synapse stability are not fully understood, 
one model is that synaptic components at the membrane are sta-
bilized through spectrin and ankyrin linkages to the cytoskele-
ton (Pielage et al., 2006, 2008; Ayalon et al., 2008; Koch et al., 
2008), and that the establishment of these connections is facili-
tated by dynein/dynactin recruitment of microtubules (Carminati 
and Stearns, 1997; Adames and Cooper, 2000; Ligon et al., 
2001; Schuyler and Pellman, 2001; Dujardin and Vallee, 2002). 
The binding of ankyrin to the p62 subunit of dynactin, as well 
as the reported binding of ankyrin to microtubules, supports   
the hypothesis that spectrin and ankyrin may act together to   
stabilize the synaptic membrane through the dynactin/dynein-
mediated capture of microtubules (Ayalon et al., 2008; Koch et al., 
2008; Pielage et al., 2008). Consistent with this model, synapse 
disassembly has also been reported after disruption of dynactin 
function (Eaton et al., 2002).
SCA5 mutations disrupt vesicle transport
Our investigations provide the first direct in vivo visualization 
of spectrin’s involvement in vesicle transport in neurons, in con-
trast to previous studies in Drosophila that indirectly suggested 
a role for -spectrin in vesicle transport based on the accumula-
tion of axonal cargos in fixed preparations of spectrin mutants 
or of motor neurons depleted of spectrins by RNAi treatment 
(Featherstone et al., 2001; Pielage et al., 2005, 2006). Here, we 
use live imaging of larval axons to directly observe the defec-
tive transport of vesicles after -spectrin depletion by RNAi 
treatment, or after expression of the SCA5 mutations that   
specifically disrupt spectrin function. In vertebrates, the initial 
studies suggesting a role for spectrin in intracellular transport 
have  been  controversial.  In  particular,  whether  vertebrate   
-III–spectrin is associated with Golgi vesicles has been com-
plicated by the cross-reactivity of -III–spectrin antisera with 
the related protein, nesprin (Beck, et al., 1994; Stankewich   
et al., 1998; Gough et al., 2003). More recent biochemical and 
in vitro motility studies (Muresan et al., 2001; Holleran et al., 
2001) suggest a model in which two Arp1-binding sites on   
-III–spectrin mediate the linkage between the dynein motor 
and cytoplasmic vesicles. In vitro imaging of protein-free lipo-
somes  or  axonal  vesicles  from  dissociated  squid  axoplasm 
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stabilization of the synaptic membrane. Phenotypes of synapse 
disassembly  are  observed  when  fly  -spectrin  expression  is   
reduced or dynactin is disrupted (Eaton et al., 2002; Pielage et al., 
2006). The synaptic deficits caused by the human SCA5 mu-
tations may affect similar pathways by disrupting membrane– 
microtubule linkages that could lead to synapse disassembly. 
On synaptic vesicles, the spectrin adapter links the dynactin/ 
dynein motor complex to the membrane, providing for transport 
of vesicles along the axonal microtubules. In our studies, we 
show that SCA5 mutations inhibit the transport of vesicles both 
to and from the synapse in axons. Similarly, vesicle transport 
within dendritic processes may be disrupted by the SCA5 mutant 
spectrins and compromise neuronal function. Because Purkinje 
cells are among the largest neurons in the human central ner-
vous system (Palay and Chan-Palay, 1974), decreased efficiency 
in transport of macromolecules, vesicles, and organelles, as 
well as the compromised stability of specialized neuronal mem-
brane domains may underlie the profound Purkinje cell loss in   
SCA5 patients.
Materials and methods
Fly stocks and genetic analyses
Flies were cultured at 25°C in a 12-h light/dark cycle on standard me-
dium. Fly stocks were obtained from the Bloomington Drosophila Stock 
Center unless indicated and are listed in FlyBase (http://flybase.org/).
To analyze transgene expression in the eye, homozygous virgins for 
each genotype were crossed to gmr-GAL4/CyO males. Progeny lacking 
curly wings were examined. Neuronal expression was driven with elav-
GAL4. Briefly, elav-GAL4/Y males were mated to homozygous virgins for 
each genotype. Female larvae were selected for further analysis.
To generate transgenic flies expressing syt-GFP in all neurons or   
n-syb-GFP  in  motor  neurons,  homozygous  virgins  carrying  wild-type  or   
mutant spectrin transgenes were crossed to either elav-GAL4–syt-GFP/Y 
(Zhang et al., 2002) or D42-GAL4–n-syb-GFP/TM6B, Tubby (Tb) males. 
GFP-positive larvae were selected for analyses.
To analyze genetic interaction of spectrin mutations with DHC64C
6-10  
(Gepner  et  al.,  1996)  and  Gl
1  (Harte  and  Kankel,  1982)  mutants  in 
the eye, standard meiotic recombination was used to generate second 
chromosomes carrying both the eye-specific gmr-GAL4 driver and either 
the hSPAM or the FSPGM transgenes. Recombinant chromosomes were 
maintained over a balancer chromosome carrying the dominant maker 
Curly (CyO). Virgin females from gmr-GAL4-hSPAM/CyO or gmr-GAL4-
FSPGM/CyO lines were mated to Dhc64C
6-10/TM6B, D or Gl
1Sb/LVM 
males. Progeny carrying the recombinant chromosomes in either the Gl
1 
or DHC64C
6-10 mutant backgrounds were identified by the absence of 
the dominant curly wing phenotype; the Gl
1 mutation was identified by 
the bristle phenotype caused by the dominant Sb mutation, whereas adult 
flies carrying the DHC64C
6-10 mutation lacked the curly and Dichaeted 
wing phenotypes.
To generate larvae expressing the American SCA5 mutation in 
all neurons in a dynein or dynactin mutant background, homozygous 
virgin females (hSPAM/hSPAM) were crossed to elav-GAL4-syn-GFP/Y; 
Dhc64C
6-10/TM6B, Tb or elav-GAL4-syn-GFP/Y; Gl
1Sb/TM6B, Tb males. 
Third instar larvae that carry GFP and lack the Tb marker were selected 
for analysis.
The RNAi transgenic stock used to deplete -spectrin in Drosophila 
larvae was provided by G. Davis (University of California, San Francisco, 
San Francisco, CA).
Generation of the UASp–-Spec and UAST--Spec transgenic flies
To  express  human  -III–spectrin  in  Drosophila,  full-length  wild-type  and 
mutant  (American  SCA5  mutation)  5  myc--III–spectrin  cDNA  clones 
(Ikeda et al., 2006) were digested with KpnI and XbaI and ligated into the   
Drosophila  transformation  vector  pUASp  (Rørth,  1998).  For  generating 
the German SCA5 transgene, the L253P mutation was introduced into the 
wild-type 5 myc-tagged -III–spectrin construct (Ikeda et al., 2006) using 
the QuikChange II XL Site-Directed Mutagenesis kit (Agilent Technologies) 
can be inhibited by the addition of competing spectrin peptides. 
In our studies, we show that SCA5 mutations in -III–spectrin 
disturb the retrograde and anterograde transport in axons.   
Velocities and run lengths of vesicles in both directions are signifi-
cantly reduced, and an elevated frequency of reversals is seen. 
The loss of unidirectional transport may indicate a decreased 
affinity in the attachment of motors to vesicular cargoes and/or 
increased  competition  and  switching  between  oppositely  di-
rected motor proteins. It will be important to understand whether 
compromising spectrin’s function directly influences the bind-
ing of motor proteins or, alternatively, alters the binding of other 
factors that regulate motor activities. Although the axonal accu-
mulations, or swellings, do not completely block the passage of 
moving cargoes, as synaptic vesicle proteins (e.g., syt, CSP, and 
syb) are transported and localized at synapses, the velocities of 
transport are reduced and, together with accumulation of intra-
cellular cargos, may contribute to neurodegeneration.
Taken together, our data suggest that SCA5 is part of a 
growing group of diseases recently shown to involve the disrup-
tion of intracellular transport (for reviews see Chevalier-Larsen 
and Holzbaur, 2006; Duncan and Goldstein, 2006; De Vos et al., 
2008). The fact that dynein and dynactin mutations enhance the 
spectrin mutant phenotypes suggests that mutant -spectrin per-
turbs spectrin–dynactin interactions and affects binding of cargo 
to dynein (Holleran et al., 2001). Additionally, our results indi-
cate that mutant spectrins do not only disrupt dynein-mediated 
retrograde transport, but also affect anterograde transport. Most 
likely, this reflects the interdependence between anterograde and 
retrograde transport that has been reported in multiple systems 
(Schroer et al., 1988; Brady et al., 1990; Waterman-Storer et al., 
1997; Martin et al., 1999; Gross et al., 2000, 2002a,b; Pilling   
et al., 2006). In addition, an increasing number of biochemical 
and functional analyses suggest that dynactin acts as a switch 
to coordinate plus- and minus-end directed motor activities   
(Deacon et al., 2003; Gross, 2003; Haghnia et al., 2007). Our 
results do not exclude the possibility that the SCA5 mutations 
could affect kinesin-based transport (Hirokawa, 1998; De Matteis 
and Morrow, 2000; Takeda et al., 2000; Paik et al., 2004), even 
though no direct association between -spectrin and kinesin-1 
has been reported in Drosophila, and SCA5 phenotypes are 
not enhanced by kinesin mutations.
The spectrin–dynactin–dynein linkage in 
neurodegeneration and SCA5
Building on spectrin’s ability to stabilize protein domains at the 
membrane, one hypothesis is that spectrin also mediates the direct 
association of dynein and dynactin with proteins in membrane-
bound cytoplasmic vesicles (Presley et al., 1997; Holleran et al., 
2001; Muresan et al., 2001). We suggest that both synapse loss 
and vesicle transport defects caused by the SCA5 mutations 
may result from disruptions in the spectrin–dynactin–dynein 
adapter complex that links both vesicle and synaptic membranes 
to microtubules. The resultant neurodegeneration likely results 
from defects in both activities of the spectrin–dynactin–dynein 
linker adapter complex. At the synaptic membrane, the spectrin 
adapter recruits dynactin and dynein to the plasma membrane, 
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were washed free of unbound antibody and incubated with precleared 
protein lysates overnight at 4°C. The protein A–Sepharose beads were 
then collected by centrifugation for 2 min at 2,500 rpm at 4°C and 
washed five times with ice-cold RIPA buffer. Bound proteins were eluted 
with 2× SDS sample buffer and subjected to SDS-PAGE and Western 
blot analysis.
Scanning electron and optical microscopy of fly eyes
For scanning EM images, fly heads were dehydrated in 100% ethanol,   
incubated in hexamethyldisilazane (Sigma-Aldrich), dried overnight under 
a vacuum, and coated with gold-palladium. Images were taken with a vari-
able pressure scanning electron microscope (S-3500N; Hitachi). For opti-
cal images, adult flies eyes were photographed with a digital camera 
(Nikon) attached to a stereoscope (Carl Zeiss, Inc.).
Eye histology
For histological analysis of eyes, heads from 10-d-old flies were fixed for 
30 min in a 2% glutaraldehyde/2% osmium tetroxide mix, washed in PBS, 
fixed  for  an  additional  3  h  in  2%  osmium  tetroxide,  and  dehydrated 
through a graded ethanol series. Heads were further equilibrated in pro-
pylene oxide and embedded in Durcupan ACM resin (Electron Microscopy 
Science). Vertical semithin sections were stained with toluidine blue and 
photographed with a microscope (AS/LMD; Leica).
Larval motility
The behaviors of larvae were compared under a stereoscope (Carl Zeiss, 
Inc.). Videos of animals expressing mutant and wild-type spectrin trans-
genes were made using a camcorder (Nikon).
Immunohistochemistry
For immunostaining of segmental nerves, wandering third instar larvae 
were dissected in 1× PBS and fixed in 4% formaldehyde for 20 min as de-
scribed previously (Hurd and Saxton, 1996). Larval fillets were washed 
three times in PBT (1× PBS and 0.1% TritonX-100) and washed for 1 h in 
PBT containing 1% BSA (PBT-BSA) before overnight incubation with pri-
mary antibodies at 4°C. Primary antibodies used were mouse anti-CSP (6D6, 
1:250; Developmental Studies Hybridoma Bank), mouse anti-dynein heavy 
chain antibody (P1H4, 1:250; McGrail and Hays, 1997), and mouse 
anti–-tubulin (DM1A, 1:200; Sigma-Aldrich).
To  examine  synaptic  morphology,  third  instar  larvae  were  pro-
cessed and stained as described in the previous paragraph, but the ven-
tral ganglia, brain, and segmental nerves were removed to facilitate NMJ 
visualization. Muscle surfaces were delimited by Alexa Fluor 488 phal-
loidin (Invitrogen) staining. Larval preparations were incubated overnight 
with primary antibodies as follows: mouse anti-futsch (22C10, 1:100), 
mouse anti–Fas II (1D4, 1:10), mouse anti–discs large (4F3, 1:50), mouse 
anti-neuroglian (BP104, 1:10; all provided by the Developmental Studies   
Hybridoma Bank, University of Iowa), and rabbit anti–Ank2-XL (1:1,000; 
a  gift  from  H.  Aberle,  Westfälische  Wilhelms-Universität  Münster,   
Münster, Germany). Signals were detected with Alexa Fluor 555, Alexa 
Fluor 488, and Cy5-conjugated secondary antibodies (Invitrogen) used 
at final concentrations of 1:200 at room temperature for 2 h. Larval 
preparations  were  washed  in  PBT-BSA  and  mounted  in  Vectashield   
(Vector Laboratories).
Images of neuromuscular preparation were acquired using an   
inverted microscope (Eclipse TE200; Nikon) equipped with a confocal 
imaging system (PerkinElmer) and a digital camera (Orca ER; Hama-
matsu Photonics). Synapse morphology and axonal staining were im-
aged using 2 × 2 binning with a 40× Plan-Apochromat (NA 1.3) and a 
100× Plan-Apochromat (NA 1.4) objective, respectively, and 1-µm opti-
cal sections. Images were processed in Photoshop CS3 and Illustrator 
CS4 (both from Adobe).
Live imaging of GFP-tagged vesicles in larval segmental axons
Motility analyses were done on neuromuscular preparations by live con-
focal  fluorescence  microscopy.  Briefly,  wandering  third  instar  larvae 
were dissected in HL3 buffer (Feng et al., 2004; Stewart and McLean, 
2004), carefully removing gut and fat body to expose segmental nerves. 
GFP vesicles were imaged at 25°C with an inverted microscope (Eclipse 
TE200; Nikon) equipped with the confocal imaging system (PerkinElmer). 
Images were acquired continuously at a rate of one frame every 1 s for 
300 s, with 2 × 2 binning and a 100× oil Plan-Apochromat (NA 1.4) 
objective, using MetaMorph software (GE Healthcare) to control a charge-
coupled device camera (Orca ER).
and primers German mutant forward (5-GGGACTTACCAAGCCGCTG-
GATCCCGAAGAC-3) and German mutant reverse (5-GTCTTCGGGATC-
CAGCGGCTTGGTAAGTCCC-3). The resulting product was cloned into 
pUASp. Generated UASp constructs containing the human spectrin (hSP) 
sequences are referred to here as hSPWT (wild-type), hSPAM (American 
mutation), and hSPGM (German mutation; Fig. S1 B).
The  construct  designed  to  overexpress  wild-type  fly  -spectrin 
(FSPWT; Fig. S1 C) was created by generating separate PCR products. 
Briefly, a partial cDNA clone (AT24411; Drosophila Genomics Resource 
Center, Indiana University, http://dgrc.cgb.indiana.edu/) containing the 
5 region of the fly -spectrin mRNA was used to amplify a KpnI–BamHI 
PCR fragment using primers fly forward KpnI (5-GACGGTACCGCCAA-
GTGAAGTTCATCC-3)  and  fly  reverse  BamHI  (5-CGTACTCATCGATG-
TACTCGTTGCC-3). The remained 3 cDNA sequence was cloned using the 
SuperScript III One-Step RT-PCR system with Platinum Taq high fidelity (Invit-
rogen), total RNA from fly embryos, and the gene-specific primers fly for-
ward BamHI (5-CAGCCATGACGACGGACATTTCG-3) and fly reverse 
XbaI  (5-AGTCTAGAGCTCTTGCTTATGGTTGCG-3).  Both  PCR  products 
were then subcloned using subsequent KpnI–BamHI and BamHI–XbaI diges-
tions into the corresponding cloning sites of pBluescript SK+ (Agilent Tech-
nologies) to generate the pBluescript SK+/-Spec wild-type clone.
The American SCA5 mutant clone (FSPAM; Fig. S1 C) was gener-
ated by a PCR approach using primers fly American-39 bp BglII for-
ward (5-CGTATATAAGATCTCGTTGGACAACATGGAGGAGATC-3) and 
Fly American-39 bp BsrGI reverse forward (5-ACATCAGCTTGTACAG-
GCTGAGGGCGT-3). The resulting PCR product, which deleted a 39-bp 
fragment in the region of homology with the deletion mutation found in the 
American SCA5 family (Fig. S1 B, I), was subcloned BglII–BsrGI into the 
pBluescript SK+/-Spec wild-type clone. Both wild-type and the American 
SCA5 mutant full-length cDNAs were then cloned with KpnI–XbaI into the 
Drosophila transformation vector pUAST (Brand and Perrimon, 1993).
The German SCA5 mutant clone (FSPGM; Fig. S1 C) was generated 
by introducing the L253P mutation into the FSPWT clone using the Quik-
Change II XL Site-Directed Mutagenesis kit and primers fly German mutant 
forward (5-CCTGGCCAAGCCCCTTGATGCCGAG-3) and fly German 
mutant reverse (5-GTCTTCGGGATCCAGCGGCTTGGTAAGTCCC-3).
The integrity of each construct was verified by sequencing. Trans-
genic flies were generated by standard P element–mediated germline trans-
formation. Multiple lines of flies with independent transgene insertion were 
established for each genotype.
Preparation of protein extracts
Adult flies for each genotype in the study were frozen in liquid nitrogen   
before heads were collected and homogenized in radio immunoprecipi-
tation assay (RIPA) lysis buffer (1× PBS, 1% Nonidet P-40, 0.5% sodium   
deoxycholate, and 0.1% SDS) supplemented with Complete Protease 
Inhibitor Cocktail Tablets (Roche). The protein supernatant was collected 
after centrifugation at 14,000 rpm for 30 min at 4°C and used for im-
munoprecipitation and Western blot analyses.
Western blot analysis
Total proteins from fly heads were separated on 4–12% gradient Nu-
PAGE gels (Invitrogen). After electrophoresis, gels were electroblotted 
overnight onto nitrocellulose membranes and incubated with -III–spectrin 
(1:250;  Santa  Cruz  Biotechnology,  Inc.),  tubulin  (1:5,000,  Sigma- 
Aldrich), or myc (1:2,000, clone 9E10; Sigma-Aldrich) antibodies. Rab-
bit polyclonal anti–Drosophila -spectrin antibody (a gift from D. Branton, 
Harvard University, Cambridge, MA) was used at a 1:5,000 dilution.   
Immunoreactive bands were visualized using HRP-conjugated secondary 
antibodies at 1:5,000 dilutions and the ECL Western blotting detection 
system (GE Heathcare). The ImageJ analysis software (National Institutes 
of Health; http://rsb.info.nih.gov/ij/) was used to quantitatively com-
pare protein expression.
Immunoprecipitation
Protein  extracts  from  fly  heads  were  precleared  by  the  addition  of   
100 µl of a 1:1 protein A–Sepharose suspension (GE Healthcare). After 
incubation on a rotator at 4°C for 2 h, this mix was centrifuged for   
5 min at 5,000 rpm. Supernatant aliquots containing 400 µg of total 
proteins were subsequently used in immunoprecipitation experiments. 
In parallel, 40 µl of protein A–Sepharose beads were equilibrated in 
RIPA buffer supplemented with protease inhibitors and further incubated 
with either 10 µg of mouse anti–Drosophila -spectrin antibody (clone 
3A9; Developmental Studies Hybridoma Bank, University of Iowa) or   
50 mg/ml of BSA during 1 h at 4°C. The antibody–bead complexes JCB • VOLUME 189 • NUMBER 1 • 2010   156
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Online supplemental material
Fig. S1 shows generation of transgenic flies expressing the SCA5 muta-
tions. Fig. S2 shows that expression of SCA5 mutant spectrin disrupts the 
morphology of NMJ synapses and the organization of the cell adhesion 
molecule Fas II. Fig. S3 shows that expression of SCA5 mutant spectrins 
does not result in synapse retraction or changes in ankyrin localization at 
NMJ synapses. Fig. S4 shows that expression of the SCA5 mutant trans-
genes does not severely disrupt the organization of the microtubule cyto-
skeleton. Fig. S5 shows analysis of human -III and Drosophila -spectrin 
protein expression in lines used for genetic interaction analysis. Video 1   
shows that Drosophila third instar larvae overexpressing wild-type fly   
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